Invasight raised €4.3M in a Seed round in Jun 2022. The company is based in Zurich, Switzerland. Investors in the round: JFG Life Sciences Foundation, OCCIDENT. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
This is the company's only recorded round.
